Skip to main navigation Skip to search Skip to main content

Multi-Omics for Mothers and Infants (MOMI) Consortium: a global initiative to study adverse pregnancy outcomes

  • Xin Tang
  • , Salahuddin Ahmed
  • , Farzana Bashir Ahmed
  • , Vincent Albrecht
  • , Vincenth Brennsteiner
  • , Alan Lee Chang
  • , Nabidul Haque Chowdhury
  • , Saikat Deb
  • , Matthew Gormley
  • , Tarik Hasan
  • , Leah Kamulaza
  • , Javairia Khalid
  • , Waqasuddin Khan
  • , Rasheda Khanam
  • , Pallavi Kshetrapal
  • , Hanqi Luo
  • , Tushar K. Maiti
  • , Arindam Maitra
  • , Mohammad Mohsin Mannan
  • , Johannes Mueller-Reif
  • Clyde Mulenga, Imran Nisar, Jesmin Pervin, Teeranan Pokaprakarn, Joni Price, Muhammad F. Qazi, Katelyn Rittenhouse, Yuri Sebastiao, Ntazana Sindano, Tulika Sinha, Shailaja Sopory, Medini Steger, Ramachandran Thiruvengadam, Nitya Wadhwa, Lei Xue, Nima Aghaeepour, Abdullah H. Baqui, Shinjini Bhatnagar, Susan Fisher, Melissa Fox, Daniela Hampel, Margaret Kasaro, Matthias Mann, Anisur Rahman, Sunil Sazawal, Liat Shenhav, Jeffrey Sa Stringer, Ge Zhang, Fyezah Jehan, Kristina De Paris

Research output: Contribution to journalArticlepeer-review

Abstract

Background: The Multi-Omics for Mothers and Infants (MOMI) Consortium aims to define biological mechanisms associated with preterm birth, small for gestational age, preeclampsia, and stillbirth. Globally, the burden of adverse pregnancy outcomes (APOs) is highest in low- and middle-income countries (LMICs). The MOMI Consortium consists of six different LMIC sites established by The Alliance for Maternal and Newborn Health Improvement in Bangladesh, Pakistan, and Tanzania, the Global Alliance to Prevent Prematurity and Stillbirth in Bangladesh and Zambia, and the Interdisciplinary Group for Advanced Research on Birth Outcomes - DBT India Initiative. It also partners with five analytical partners and three bioinformatic teams. Methods: The combined MOMI cohort includes 24 321 pregnant women, a rich biorepository, and paired socioeconomic and clinical data. Considering the multifactorial aetiologies and molecular drivers of APOs, we applied an integrative multi-omics (genomics, metabolomics, proteomics, nutrient testing) approach to identify site-specific and cohort-wide signatures linked to distinct APOs. Conclusions: This protocol summarises the MOMI study design, sample and data collection methods, data harmonisation, and the various analytics platforms, and discusses potential outcomes for enhanced clinical care and novel diagnostic and therapeutic tools.

Original languageEnglish (US)
Pages (from-to)5002
Number of pages1
JournalJournal of Global Health
Volume16
DOIs
Publication statusPublished - 3 Apr 2026

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Multi-Omics for Mothers and Infants (MOMI) Consortium: a global initiative to study adverse pregnancy outcomes'. Together they form a unique fingerprint.

Cite this